Summary. The aim of the study was to investigate the effect of inhibitors of mitochondrial respiratory chain complexes I, III, and IV
Introduction
Heart failure is one of the most dangerous pa thologies that occurs as an end stage of different heart diseases, such as hypertension, myocardial infarction or idiopathic, dilated, restrictive cardio myopathies (1, 2) . Currently, a lot is done in the di agnosis and treatment of this pathology but increas ing mortality due to heart failure nevertheless is still one of the most relevant problems in the present day medicine.
Contractility, the main function of heart, is trig gered by Ca 2+ ions and their interaction with con tractile proteins of cardiomyocytes. Ca 2+ enters the cell during depolarization via sarcolemmal slow (L type) Ca 2+ channels and triggers Ca 2+ release from sarcoplasmic reticulum (SR) via ryanodine recep tors (RyR) (3) . Sarcolemmal Ca 2+ pump (Ca 2+ -AT Pase), Na + -Ca 2+ exchanger, SR Ca 2+ -ATPase, and phospholamban (PLB) also play an important role in the process of myocardial contraction-relaxation. The energy derived from hydrolysis of adenosine triphosphate (ATP) is essential for functioning of all the systems that regulate cardiac contraction-relax ation. A decrease in intracellular ATP concentration impairs the function of these energydependent cell systems and leads to an increase in the intracellu lar concentrations of Na + and Ca 2+ ions (Ca 2+ over load), decreases myocardial contraction force, and provokes the development of heart failure, arrhyth mias, and necrosis of cardiomyocytes (1, 4) .
About 80% to 90% of cellular ATP is produced by mitochondrial oxidative phosphorylation; the most part of generated ATP (>60%) is consumed for the con traction-relaxation of myocardium (5) . Mitochondrial F 1 F 0 -ATP synthase uses the proton gradient, generated by complexes I, III, and IV of the electron transport chain, to generate ATP from ADP. Altered activity of these complexes can cause a reduction in the mito chondrial electrochemical gradient and ATP synthesis (6, 7) . A variety of studies demonstrated that patients suffering from idiopathic dilated cardiomyopathy or is chemia have impaired activity of mitochondrial respira tory chain complexes I (8-10), III (11) (12) (13) (14) , and IV (11, 15) . Thus, impaired function of mitochondria could be one of the main reasons causing heart failure. However, there is a lack of integrated studies on the infl uence of impairment of every separate respiratory chain complex activity on the human cardiac contraction, relaxation, and action potential. Therefore, the aim of this study was to investigate the effect of inhibitors of mitochondrial respiratory chain complexes I, III, and IV on the electromechanical activity in human myocardium.
Material and methods
The experiments were performed on human left ventricular strips (0. 9 .59±0.92 mg in weight) were cut from the pieces of heart tissue in the same solution. The preparations were then placed in an experimental chamber and superfused with oxygenated Tyrode solution, containing (in mM): 137 NaCl, 5.4 KCl, 1.8 CaCl 2 , 0.9 MgCl 2 , 5 glucose, 10 HEPES, pH 7.4, pO 2 580-600 mm Hg. Constant fl ow was kept at the rate of 4 mL/min, and temperature was continuously monitored and kept at 36.0°C±0.5°C. Isometric contraction was recorded using a linear force-displacement transducer (Harvard Apparatus, USA), and action potentials were registered with glass microelectrodes fi lled with 2.5 M KCl. The cardiac samples were continuously paced with chlorine-coated silver electrodes at a frequency of 1 Hz with rectangular pulses of 2-5 ms in duration, and 3-4-fold greater amplitude than diastolic threshold. Contraction force (P), half time of relaxation (t 50 ), resting tension (contracture), action potential (AP) duration at 50% (AP 50 ) and 90% (AP 90 ) of repolarization were recorded and analyzed using specialized custom-made computer software. In control, i.e., during perfusion with Tyrode solution, values of contraction force, relaxation time, and AP durations were set at 100%. Changes in these parameters are given in percent (±standard error) of control level. Differences in resting tension are presented in relative units in regard to values of contraction force in control. For statistical evaluation, Student's t test was used, and differences were considered statistically signifi cant when P<0.05. Rotenone, antimycin A, and O 2 scavenger sodium dithionite (Na 2 S 2 O 4 ) were used to block activity of respiratory chain complexes I, III, and IV, respectively, and glibenclamide was used to block ATP-dependent K + channels. All the drugs used in experiments were from Sigma-Aldrich.
Results
Under perfusion with Tyrode solution (control), contraction force of human ventricular strips was 0.94±0.12 mN (n=16); half time of relaxation, 173.38±5.03 ms (n=15); AP 50 , 248.96±13.38 ms; and AP 90 , 398.59±17.93 ms (n=13). Fig. 1 demonstrates original traces of contraction (A) and action potentials (B), and changes in contraction force (curve 1) and relaxation time (curve 2) (C) under the infl uence of rotenone, an inhibitor of mitochondrial respiratory chain complex I. Rotenone (10 -6 M to 3×10 -5 M) in a concentrationdependent manner reduced contraction force of human ventricular strips. The greatest reduction in P, i.e., to 48.99%±14.74% (n=3) of control level, was observed at the highest concentration of rotenone (3×10 -5 M) (P<0.05). During reperfusion with Tyrode solution, P partly recovered to 68.95%±21.18% (n=5) (P>0.05). Rotenone had no signifi cant effect on relaxation time of human myocardium; even at 3×10 -5 M, t 50 was 97.13%±5.82% (n=5). However, reperfusion with rotenone-free physiological saline increased t 50 to 123.47%±17.24% (n=5) (P<0.05). Rotenone caused insignifi cant shortening of action potentials; at 3×10 -5 M of this inhibitor, AP 50 and AP 90 decreased to 81.34%±15.81% and 87.28%±7.25% (n=3), respectively (P>0.05) (Fig. 1B) . The resting tension of human myocardium was not affected by rotenone. Fig. 2 shows the effect of antimycin A, an inhibitor of mitochondrial respiratory chain complex III, on electromechanical activity of human myocardium. As shown in Fig. 2A and C (Fig. 2B) . The inhibition of respiratory chain complex III activity by antimycin A as well as inhibition of complex I by rotenone had no effect on resting tension of human ventricular strips.
The activity of mitochondrial respiratory chain complex IV was inhibited by anoxia. During experiments, human ventricular strips were perfused with Tyrode solution containing 3×10 -3 M sodium dithionite (Na 2 S 2 O 4 ) that scavenges O 2 molecules in the solution and reduces the oxygen tension to zero. Fig. 3 shows original traces of contraction (A) and action potentials (B), and change of contraction force (C) under the infl uence of anoxia. The inhibitory effect of anoxia on contraction force was obvious already after the fi rst minutes of perfusion with anoxic solution, and after 50 minutes, P was reduced to 9.23%±3.56% (n=6; P<0.001). (Fig. 3B) .
Discussion
Our experimental data show that inhibition of mitochondrial respiratory chain complex I by rotenone, complex III by antimycin A, and complex IV by anoxia decreased contraction force, duration of action potentials and did not affect or marginally increased relaxation time and resting tension of human myocardium. The inhibition of respiratory chain complex IV by anoxia had the most obvious inhibitory effect on these parameters. It is known that mitochondrial respiratory chain complexes I, III, and IV function as proton pumps and pass protons from the matrix to the intermembrane space of mitochondria during electron transport. This process results in the generation of electrochemical potential that is necessary for ATP production (16) . Electrons of oxidative substrates can pass to electron transport chain not only through complex I (NADH dehydrogenase), but also through complex II (succinate dehydrogenase). This may explain why the inhibition of complex I by rotenone in our experiments did not elicit a strong inhibitory effect on the parameters of electromechanical activity of human myocardium. Similar results were obtained by Sward et al. (17) , who found that the inhibitory effect of rotenone on intracellular Ca 2+ concentration, which is proportional to contraction force alterations in rat smooth muscles, was smaller than one of antimycin A.
Duchen (16) demonstrated that under the inhibition of complex IV activity, the electron transport along mitochondrial respiratory chain stops and electrochemical gradient, essential for ATP synthesis, collapses, and consequently ATP level decreases in myocardial cells. It has been demonstrated that during ischemia, when the activity of respiratory chain complex IV is blocked due to lack of O 2 , intracellular ATP level in ferret cardiomyocytes decreased by 90%, i.e., from 5-10 mM to <100 μM (18) . Perfusion with glucose-free physiological saline containing rotenone, an inhibitor of complex I, decreased ATP level by 67% in canine ventricular myocytes (19) . Li et al. found that the inhibition of respiratory chain complex IV by cyanide resulted in a rapid (within 2 min) fall in ATP level by 60% in epithelial cells of opossum kidney (20) .
Sarcolemmal ATP-dependent K + channels (K ATP ) that open due to reduction of intracellular ATP ([ATP] i ) and consequently shortening of action potentials serve as an indirect indicator of the reduction in cellular ATP content in myocardial cells (21, 22) . If AP shortens due to reduction of [ATP] i , the blocking of K ATP channels by glibenclamide has to increase AP duration. We have found that action potential duration AP 90 of human myocardium shortened by anoxia to 71.07%±8.39% was then prolonged to 93.77%±8.3% by blocking of K ATP by glibenclamide. Previous studies of our laboratory also have shown that action potential duration of guinea pig myocardium decreased during hypoxia, and under the action of an inhibitor of ATP-dependent K + channels -glibenclamide -AP duration was restored (23) . These data confi rm the fact that ATP level in myocardial cells decreases during the inhibition of respiratory chain complex IV activity, and therefore, myocardial contraction force and action potential duration decrease in concert with it.
Decreased cellular ATP concentration results not only in opening of sarcolemmal ATP-dependent K + channels and shortening of action potential, but also in impairment of functioning of other cellular systems dependent on ATP, including sarcolemmal L-type Ca 2+ channels, Na + -K + ATPase, Na + -Ca 2+ exchanger, sarcoplasmic reticulum Ca 2+ -ATPase, phospholamban, RyR channels (1, 4 (4, 24) . Ca 2+ overload leads to an increased level of formation of actin-myosin crossbridges. However, ATP is necessary for breakdown of these cross-bridges (interaction cycle of muscle myosin with actin requires roughly 75% of cellular ATP [25] ); therefore, the relaxation of muscle slows down, i.e., relaxation time increases, contracture of cardiac cells starts to develop. In our experiments, relaxation time of human myocardium was not changed or marginally increased under inhibition of respiratory chain complexes I and III activity while contracture developed only under inhibition of complex IV by anoxia. As there was no possibility to perform such experiments on healthy human myocardium, our experiments were carried out on ventricular preparations obtained from patients with NYHA class III or IV heart failure. Our previous investigations with rat myocardium showed that inhibition of the activity of mitochondrial respiratory chain complexes signifi cantly stronger decreased contraction force and action potential duration, increased relaxation time if compared with human myocardium, and contracture of rat myocardium developed not only under inhibition of the activity of complex IV, but also complex III (26) . A number of studies have demonstrated that myocardial remodeling occurs in heart failure resulting in changes of heart activity and regulation, i.e., reduction in muscle contraction force, slowing down relaxation, reduction in the sensitivity of cardiomyocytes to Ca 2+ ions and catecholamines, decrease in the content of SR Ca 2+ -ATPases, increase in Na + -Ca 2+ exchanger activity (3, 27, 28) . Remodeling may be a reason of smaller change in electromechanical activity parameters of human myocardium than in rat myocardium during inhibition of the activity of mitochondrial respiratory chain complexes. The results suggest that failing myocardium can be less sensitive to metabolic changes caused by inhibitors of oxidative phosphorylation.
Conclusions
The inhibition of mitochondrial respiratory chain complexes I, III, and IV activity (by rotenone, antimycin A, and anoxia, respectively) decreased contraction force, action potential duration, but did not affect or marginally slowed down relaxation of failing human myocardium.
The inhibition of mitochondrial respiratory chain complex IV had the strongest inhibitory effect on electromechanical activity of failing human myocardium. Rezultatai. Kvėpavimo grandinės I komplekso slopiklio rotenono koncentracijai didėjant iki 3×10 -5 M, P mažėjo iki 48,99±14,74 proc. (n=3) (p<0,05), atsipalaidavimo laikas bei ramybės įtampa beveik nekito, VP 50 ir VP 90 sumažėjo atitinkamai iki 81,34±15,81 proc. bei 87,28±7,25 proc. (n=3) (p>0,05) palyginus su kontrole. Antimicinas A, III komplekso aktyvumo slopiklis, didinant jo koncentraciją iki 3×10 -4 M, sumažino P iki 41,66±8,8 proc. (n=5) (p<0,001), nežymiai padidino t 50 bei sumažino VP trukmes. Slopinant IV komplekso aktyvumą anoksija (3 mM Na 2 S 2 O 4 ), susitraukimo jėga, palyginus su kontrole, sumažėjo iki 9,23±3,56 proc. (n=6) (p<0,001), VP 50 ir VP 90 -atitinkamai iki 65,46±9,95 proc. ir 71,07±8,39 proc. (n=5) (p<0,05), didėjo ramybės įtampa (vystėsi kontraktūra).
Mitochondrijų kvėpavimo grandinės kompleksų slopiklių
Išvados. Taigi, mūsų atliktų tyrimų duomenimis, didžiausią slopinamąjį poveikį žmonių, sergančių šir-dies nepakankamumu, miokardo elektromechaniniam aktyvumui sukėlė mitochondrijų kvėpavimo grandinės IV komplekso aktyvumo slopinimas.
